Amjevita 72511-0479

Generic: Adalimumab-Atto

Product NDC

72511-0479

Manufacturer: Amgen Usa Inc.
Dosage Form: Injection
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: November 8, 2024
Listing Expires: December 31, 2026
Application: BLA761024

Need to source Amjevita? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Adalimumab	40 mg/.4mL

Drug Class

Tumor Necrosis Factor Blocker [EPC]AntibodiesMonoclonal [CS]

Packaging Options(1)

72511-0479-02

2 SYRINGE in 1 CARTON (72511-479-02) / .4 mL in 1 SYRINGE

View →